Portal
Armon Sharei, PhD is the Founder and CEO of Portal, where Armon is developing the 'intel inside' that can power a new generation of therapeutics. Previously, Armon served as the Chief Executive Officer and Founder of SQZ Biotech, leading a team of over 100 scientists, clinicians, and specialists in creating powerful cell therapies for patients. Armon has a strong background in Chemical Engineering, with a PhD from Massachusetts Institute of Technology and postdoctoral fellowship from Harvard Medical School. Currently, Armon is an advisory council member at Pear VC for the Bio and Healthcare sector.
This person is not in any teams
Portal
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics